CClinicalTrials.gg
TerminatedNCT03152162Updated Oct 25, 2023

A Prospective Study to Evaluate the ConforMIS iTotal® (PS) Knee Replacement System

An observational study in Osteoarthritis, Knee, sponsored by Restor3D. Terminated at 4 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-10-25.

Sponsored by Restor3D · Observational

Why this study was terminated
Decision of investigational team
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
102
Ages
18 Years and older
Sex
All
01

Study summary

This is a prospective clinical study designed to observe the long-term clinical outcomes of total knee arthroplasty using a patient-specific, posterior stabilized implant in patients with osteoarthritis.

Read the detailed description

The study is prospective. Subjects will be implanted with an iTotal® PS Knee Replacement System. The study will include a minimum of 100 subjects across up to 10 sites. The patients enrolled in this study may represent the first cases of the iTotal PS KRS implanted at a particular site; data collected for the first 15 patients at each site will be analyzed separately from the rest of the enrolled population. This will provide visibility towards determining if there exists a learning curve in the implantation process of the iTotal PS KRS. The study sites will be located in the United States.

02

Conditions studied

  • Osteoarthritis, Knee

Keywords

  • osteoarthritis
  • patient-specific
  • knee replacement
  • TKA
  • knee arthroplasty
  • total knee replacement
  • posterior stabilized
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with osteoarthritis of the knee

Inclusion criteria

  • Clinical condition included in the approved Indications For Use for the iTotal® PS
  • Osteoarthritis, as confirmed by the investigator's assessment of disease status at screening visit that warrants a TKR procedure. Disease status is assessed by Clinical and Radiographic assessment.
  • Willingness to participate in the clinical study, to give informed consent, and to attend all follow-up visits
  • > 18 years of age

Exclusion criteria

Exclusion Criteria:

  • Simultaneous bilateral procedure required
  • BMI > 40
  • Active malignancy (defined as a history of any invasive malignancy - except non- melanoma skin cancer), unless patient has been treated with curative intent and there have been no clinical signs or symptoms of the malignancy for at least 5 years
  • Poorly controlled diabetes
  • Neuromuscular conditions which prevent patient from participating in study activities
  • Active local or systemic infection
  • Immunocompromised
  • Fibromyalgia or other general body pain related condition
  • Rheumatoid arthritis or other forms of inflammatory joint disease
  • Loss of bone or musculature, osteonecrosis, neuromuscular or vascular compromise in the area of the joint to be operated on, to an extent that the procedure is unjustified
  • Diagnosed with or receiving treatment for Osteoporosis
  • Other physical disability affecting the hips, spine, or contralateral knee
  • Severe instability due to advanced loss of osteochondral structure
  • Prior arthroplasty of the affected knee, including High Tibial Osteotomy (HTO)
  • Unwilling or unable to comply with study requirements
  • Participation in another clinical study which would confound results
  • Allergy to any of the implant materials
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
102 participants (actual)
Patient registry
No

Interventions

  • DeviceiTotal PS KRS

    Total knee arthroplasty for treatment of osteoarthritis

    Also known as: ConforMIS iTotal PS

05

What researchers measure

Primary outcomes

  1. Change in Baseline from 1-Year in KSS

    Change in Knee Society Scores from the pre-operative visit to the 1-year post-operative visit. The Knee Society Score (KSS) includes an Objective Knee Score, Function Score, Satisfaction Score, and Expectation Score. The objective knee score, completed by the surgeon, includes a VAS score of pain walking on level ground and on stairs or inclines, as well as an assessment of alignment, ligament stability, and ROM, along with deductions for flexion contracture or extensor lag. Patients then record their satisfaction, functional activities, and expectations (Scuderi et al., 2012).

    Time frame: 2 Years

Secondary outcomes

  1. Change from baseline in KSS at years 2, 5 and 10 post-implantation

    The Knee Society Score includes an Objective Knee Score, Function Score, Satisfaction Score, and Expectation Score. The Knee Society Score (KSS) includes an Objective Knee Score, Function Score, Satisfaction Score, and Expectation Score. The objective knee score, completed by the surgeon, includes a VAS score of pain walking on level ground and on stairs or inclines, as well as an assessment of alignment, ligament stability, and ROM, along with deductions for flexion contracture or extensor lag. Patients then record their satisfaction, functional activities, and expectations (Scuderi et al., 2012).

    Time frame: Up to 10 years

  2. Change from baseline in KOOS at years 1, 2, 5 and 10 post-implantation

    The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a 42 question knee-specific instrument, developed to assess the patients' opinion about their knee and associated problems.

    Time frame: Up to 10 years

  3. Post-operative limb alignment if long leg x-rays available

    Comparison of limb alignment between pre-operative and post-operative x-rays.

    Time frame: 2 years

  4. Length of hospital stay in hours

    How long the patient is in the hospital from the time of admission to the time of discharge.

    Time frame: 1 year

  5. Blood loss during surgery

    Estimated blood loss during surgery (mL)

    Time frame: 1 year

  6. Transfusion rate

    Rate of patients who require blood transfusions during surgery

    Time frame: 1 year

Other outcomes

  1. Revision rates post-implantation

    Rate of patients that require a revision of the total knee replacement for any reason.

    Time frame: Collected from the date of implantation to the end of the study. Up to 10 years.

  2. Length of procedure: Skin to Skin

    The duration of the knee arthroplasty starting from the time the surgeon makes the first incision and ending when the surgeon sutures the initial incision.

    Time frame: 1 year

06

Study locations

4 sites
  • UNC Orthopedics
    Chapel Hill, North Carolina 27599, United States
  • Texas Institute for Hip & Knee Surgery
    Austin, Texas 78751, United States
  • Mansfield Orthopaedics
    Morrisville, Vermont 05661, United States
  • Scott Orthopedic
    Huntington, West Virginia 25702, United States
07

References and documents

Publications

  • Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89(4):780-5. doi: 10.2106/JBJS.F.00222. PubMed 17403800 ↗
  • Rougraff BT, Heck DA, Gibson AE. A comparison of tricompartmental and unicompartmental arthroplasty for the treatment of gonarthrosis. Clin Orthop Relat Res. 1991 Dec;(273):157-64. PubMed 1959265 ↗
  • Fitzpatrick C, FitzPatrick D, Lee J, Auger D. Statistical design of unicompartmental tibial implants and comparison with current devices. Knee. 2007 Mar;14(2):138-44. doi: 10.1016/j.knee.2006.11.005. Epub 2006 Dec 22. PubMed 17188876 ↗
  • Fitz W. Unicompartmental knee arthroplasty with use of novel patient-specific resurfacing implants and personalized jigs. J Bone Joint Surg Am. 2009 Feb;91 Suppl 1:69-76. doi: 10.2106/JBJS.H.01448. PubMed 19182028 ↗
  • Bourne RB, Chesworth BM, Davis AM, Mahomed NN, Charron KD. Patient satisfaction after total knee arthroplasty: who is satisfied and who is not? Clin Orthop Relat Res. 2010 Jan;468(1):57-63. doi: 10.1007/s11999-009-1119-9. PubMed 19844772 ↗
  • Noble PC, Conditt MA, Cook KF, Mathis KB. The John Insall Award: Patient expectations affect satisfaction with total knee arthroplasty. Clin Orthop Relat Res. 2006 Nov;452:35-43. doi: 10.1097/01.blo.0000238825.63648.1e. PubMed 16967035 ↗
  • Scuderi GR, Bourne RB, Noble PC, Benjamin JB, Lonner JH, Scott WN. The new Knee Society Knee Scoring System. Clin Orthop Relat Res. 2012 Jan;470(1):3-19. doi: 10.1007/s11999-011-2135-0. No abstract available. PubMed 22045067 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03152162
Lead sponsor
Restor3D
Responsible party
Sponsor
First posted
May 12, 2017
Start date
May 1, 2017
Primary completion
Nov 1, 2022
Completion
Nov 1, 2022
Last update
Oct 25, 2023

Study contacts

Marc Quartulli
study director · Restor3D

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion